Debt to Equity Ratio Analysis of aTyr Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY Debt to Equity
Period Ending - Dec-23
Excellent Debt to Equity
0.0146
Period Ending - Dec-22
Excellent Debt to Equity
0.0125
Growth
17.10 %
Most recent Quarter Debt to Equity
Period Ending - Mar-24
Excellent Debt to Equity
0.0134
Debt to Equity Analysis of aTyr Pharma Inc
| Debt to Equity Ratio 0.0146 of aTyr Pharma Inc indicates to run a business company uses lower amount of long-term debt. |
| Debt to Equity Ratio of LIFE has grown by 17.10 % Compared to previous Financial Year. |
| Debt to Equity Ratio with value of 0.448 was highest in Year Dec-19 in last Five Years. |
| Debt to Equity Ratio with value of 0.0090 was lowest in Year Dec-21 in last Five Years. |
| Latest Debt to Equity Ratio with value of 0.0146 is lower than Average Debt to Equity of 0.102 in last five years. |
Other Debt to Equity Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LIFE | 2.0 | 1.93 | 3.63 % | Biotechnology |
Defination of Debt to Equity Ratio
Debt to Equity Ratio shows the relationship between the company's total debt and total shareholders fund. And it indicates the ability of a company's shareholders' equity to pay its debt obligations in a tough time. more ..
Debt to Equity Related Ratios
| ShortTermDebtToEquityRatio | DividendCoverageRatio | CurrentRatio |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to Equity Ratio of aTyr Pharma Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to Equity | 0.0146 | 0.0125 | 0.0090 | 0.0272 | 0.448 | 0.476 | 0.307 |
| Change | 17.10 % | 39.52 % | -67.04 % | -93.93 % | -5.95 % | 55.11 % | 102.24 % |
FY Chart of Debt to Equity Ratio of aTyr Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)